Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Kill Curves versus MIC

Por Mueller, Markus, de la Peña, Amparo, Derendorf, Hartmut
Publicado em 2004

Application of PK/PD Modeling and Simulation to Dosing Regimen Optimization of High-Dose Human Regular U-500 Insulin

Por de la Peña, Amparo, Ma, Xiaosu, Reddy, Shobha, Ovalle, Fernando, Bergenstal, Richard M., Jackson, Jeffrey A.
Publicado no J Diabetes Sci Technol (2014)

Subcutaneous Injection Depth Does Not Affect the Pharmacokinetics or Glucodynamics of Insulin Lispro in Normal Weight or Healthy Obese Subjects

Por de la Peña, Amparo, Yeo, Kwee P., Linnebjerg, Helle, Catton, Edward, Reddy, Shobha, Brown-Augsburger, Patricia, Morrow, Linda, Ignaut, Debra A.
Publicado no J Diabetes Sci Technol (2015)

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL

Por de la Peña, Amparo, Seger, Mary, Soon, Danny, Scott, Adam J., Reddy, Shobha R., Dobbins, Michael A., Brown‐Augsburger, Patricia, Linnebjerg, Helle
Publicado no Clin Pharmacol Drug Dev (2015)

Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR® inhaled insulin pharmacokinetics and glucodynamics

Por Pan, Alan X, de la Peña, Amparo, Yeo, Kwee P, Chan, Clark, Loh, Mei T, Wise, Stephen D, Silverman, Bernard L, Muchmore, Douglas B
Publicado em 2008

Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects

Por de la Peña, Amparo, Riddle, Matthew, Morrow, Linda A., Jiang, Honghua H., Linnebjerg, Helle, Scott, Adam, Win, Khin M., Hompesch, Marcus, Mace, Kenneth F., Jacobson, Jennie G., Jackson, Jeffrey A.
Publicado em 2011